| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |